Category Archives: News

RESTEM Developing First-in-Class, Umbilical Cord Lining Stem Cell Therapies. JAR of Hope Providing Critical Philanthropic Financial Support for Clinical Trial. CORONA, CALIF. AND ASBURY PARK, N.J. (PRWEB) SEPTEMBER 06, 2022 RESTEM, a pioneering, next-generation, clinical-stage cell therapy company focused on harnessing the unique power of cell therapy and JAR of Hope, a 501(3)(C) non-profit foundation dedicated […]

Published: Aug 2, 2022 By: Bill Levesque The University of Florida Center for Regenerative Medicine today announced the launch of a clinical trial to test safe dosages of umbilical cord-derived stem cells in the treatment of two debilitating autoimmune disorders. The Phase I trial, in collaboration with the biotechnology company RESTEM, will include nine patients who will receive intravenous […]